Evidence map›Paper›PMID 41627384›Full record

ArticleJournal of addiction medicine2026

High Levels of Substance Use Disorder Among Critically Ill Virginia Medicaid Beneficiaries.

Sarah J Marks, Jason Lowe, Jennifer N Catlin, Brandon Wills, Andrew J Barnes, Theodore J Iwashyna

Abstract read
In one paragraph

Article in Journal of addiction medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jason Lowe
Jennifer N Catlin
Brandon Wills
Andrew J Barnes
Theodore J Iwashyna

Funding

Understanding how health determinants shape recovery after critical illness among Virginia Medicaid patientsF30MD019536 · NIMHD · VIRGINIA COMMONWEALTH UNIVERSITY · PI Sarah Julia Marks · 2024 to 2026
$132k
Department of Medical Assistance Services IAG 407NIMHD NIH HHS F30 MD019536
6 · The paper itself

Abstract

objectivesSubstance use disorder (SUD) affects critically ill patients before, during, and after their intensive care unit (ICU) stay. Medicaid is the primary payor for patients with SUD and an increasing number of ICU stays; however, little is known about the prevalence of SUD among Medicaid-covered ICU beneficiaries.

methodsUsing Medicaid claims from Virginia in 2023-2024, we examined the prevalence of SUD, demographic characteristics, specific types of SUD, and SUD-related characteristics among Medicaid beneficiaries ages 18-64 with an ICU and compared these ICU beneficiaries to 2 groups: beneficiaries with a non-ICU hospitalization and beneficiaries with no acute hospitalizations.

resultsNearly half of Medicaid ICU beneficiaries have a SUD [49.2% (95% CI: 48.3-50.1)], over 8 times higher than general Medicaid and >20% higher than beneficiaries with non-ICU hospitalizations. Almost one in 5 ICU beneficiaries [19.2% (95% CI: 18.3%-19.8%)] had a stay for overdose or withdrawal, twice the rate of Medicaid beneficiaries with a non-ICU hospitalization. SUD was more prevalent among beneficiaries with an ICU hospitalization across most beneficiary demographic characteristics and types of SUD with alcohol and "other" (polysubstance/unknown) SUD relatively greater among beneficiaries with an ICU hospitalization compared with beneficiaries with non-ICU hospitalizations and all beneficiaries.

conclusionsSUD is highly prevalent among Medicaid beneficiaries with an ICU hospitalization. Further studies are required to understand the needs of critically ill patients with SUD. Efforts by Medicaid and managed care organizations to promote SUD treatment during hospitalization may improve the long-term recovery of critically ill patients.

Indexed as

critical careintensive care unitMedicaidsubstance use disorder

Identifiers

PMID41627384
PMCPMC13154171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.